Annual Accounts Payable
$1.40 M
+$795.60 K+132.51%
December 31, 2023
Summary
- As of February 20, 2025, LPCN annual accounts payable is $1.40 million, with the most recent change of +$795.60 thousand (+132.51%) on December 31, 2023.
- During the last 3 years, LPCN annual accounts payable has fallen by -$201.20 thousand (-12.60%).
- LPCN annual accounts payable is now -12.60% below its all-time high of $1.60 million, reached on December 31, 2020.
Performance
LPCN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$285.30 K
-$163.50 K-36.43%
September 30, 2024
Summary
- As of February 20, 2025, LPCN quarterly accounts payable is $285.30 thousand, with the most recent change of -$163.50 thousand (-36.43%) on September 30, 2024.
- Over the past year, LPCN quarterly accounts payable has stayed the same.
- LPCN quarterly accounts payable is now -82.76% below its all-time high of $1.65 million, reached on March 31, 2020.
Performance
LPCN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
LPCN Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +132.5% | 0.0% |
| 3 y3 years | -12.6% | -44.9% |
| 5 y5 years | +108.0% | -44.9% |
LPCN Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +132.5% | -79.6% | at low |
| 5 y | 5-year | -12.6% | +132.5% | -82.8% | at low |
| alltime | all time | -12.6% | >+9999.0% | -82.8% | +7215.4% |
Lipocine Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $285.30 K(-36.4%) |
| Jun 2024 | - | $448.80 K(-33.2%) |
| Mar 2024 | - | $671.40 K(-51.9%) |
| Dec 2023 | $1.40 M(+132.5%) | $1.40 M(+26.8%) |
| Sep 2023 | - | $1.10 M(+112.7%) |
| Jun 2023 | - | $517.60 K(-35.0%) |
| Mar 2023 | - | $796.50 K(+32.7%) |
| Dec 2022 | $600.40 K(-53.4%) | $600.40 K(-4.8%) |
| Sep 2022 | - | $630.50 K(-22.5%) |
| Jun 2022 | - | $814.00 K(+73.2%) |
| Mar 2022 | - | $469.90 K(-63.6%) |
| Dec 2021 | $1.29 M(-19.3%) | $1.29 M(+77.7%) |
| Sep 2021 | - | $725.60 K(-20.0%) |
| Jun 2021 | - | $906.50 K(+62.4%) |
| Mar 2021 | - | $558.30 K(-65.0%) |
| Dec 2020 | $1.60 M(+35.1%) | $1.60 M(+52.4%) |
| Sep 2020 | - | $1.05 M(+15.5%) |
| Jun 2020 | - | $906.80 K(-45.2%) |
| Mar 2020 | - | $1.65 M(+40.0%) |
| Dec 2019 | $1.18 M(+76.1%) | $1.18 M(-13.1%) |
| Sep 2019 | - | $1.36 M(+1072.8%) |
| Jun 2019 | - | $116.00 K(-77.6%) |
| Mar 2019 | - | $517.70 K(-22.9%) |
| Dec 2018 | $671.30 K | $671.30 K(+179.8%) |
| Sep 2018 | - | $239.90 K(-41.0%) |
| Jun 2018 | - | $406.50 K(+4.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $388.40 K(-35.1%) |
| Dec 2017 | $598.10 K(+143.2%) | $598.10 K(-25.6%) |
| Sep 2017 | - | $803.80 K(-27.8%) |
| Jun 2017 | - | $1.11 M(+30.5%) |
| Mar 2017 | - | $853.50 K(+247.1%) |
| Dec 2016 | $245.90 K(-51.5%) | $245.90 K(-71.6%) |
| Sep 2016 | - | $865.00 K(-12.5%) |
| Jun 2016 | - | $989.00 K(-8.2%) |
| Mar 2016 | - | $1.08 M(+112.4%) |
| Dec 2015 | $507.10 K(+65.6%) | $507.10 K(+11.0%) |
| Sep 2015 | - | $456.80 K(+14.5%) |
| Jun 2015 | - | $398.80 K(+5.1%) |
| Mar 2015 | - | $379.50 K(+23.9%) |
| Dec 2014 | $306.30 K(-70.2%) | $306.30 K(-23.3%) |
| Sep 2014 | - | $399.10 K(-37.8%) |
| Jun 2014 | - | $641.80 K(-17.0%) |
| Mar 2014 | - | $773.00 K(-24.7%) |
| Dec 2013 | $1.03 M(+8677.8%) | $1.03 M(-30.8%) |
| Sep 2013 | - | $1.48 M(+8424.7%) |
| Jun 2013 | - | $17.40 K(+18.4%) |
| Mar 2013 | - | $14.70 K(+25.6%) |
| Dec 2012 | $11.70 K(+58.1%) | $11.70 K(+72.1%) |
| Sep 2012 | - | $6800.00(+74.4%) |
| Jun 2012 | - | $3900.00(-45.1%) |
| Mar 2012 | - | $7100.00 |
| Dec 2011 | $7400.00 | - |
FAQ
- What is Lipocine annual accounts payable?
- What is the all time high annual accounts payable for Lipocine?
- What is Lipocine annual accounts payable year-on-year change?
- What is Lipocine quarterly accounts payable?
- What is the all time high quarterly accounts payable for Lipocine?
- What is Lipocine quarterly accounts payable year-on-year change?
What is Lipocine annual accounts payable?
The current annual accounts payable of LPCN is $1.40 M
What is the all time high annual accounts payable for Lipocine?
Lipocine all-time high annual accounts payable is $1.60 M
What is Lipocine annual accounts payable year-on-year change?
Over the past year, LPCN annual accounts payable has changed by +$795.60 K (+132.51%)
What is Lipocine quarterly accounts payable?
The current quarterly accounts payable of LPCN is $285.30 K
What is the all time high quarterly accounts payable for Lipocine?
Lipocine all-time high quarterly accounts payable is $1.65 M
What is Lipocine quarterly accounts payable year-on-year change?
Over the past year, LPCN quarterly accounts payable has changed by $0.00 (0.00%)